Related Experiment Video
Updated: Jun 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Systematic review on evidence of the effectiveness of cholesterol-lowering drugs
Abhaya Gupta1, Veronique Guyomard, M Justin S Zaman
1Department of Medicine, West Wales Hospital, Carmarthen, Wales, UK.
Insights
Pharmacological agents effectively lower cholesterol, a key factor in coronary heart disease (CHD). Shifting population risk profiles can significantly reduce the global burden of CHD.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Coronary heart disease (CHD) is a leading global cause of death.
- Increasing urbanization and aging populations are projected to raise CHD risk factors like hypercholesterolemia.
- This review examines pharmacological interventions for cholesterol lowering.
Purpose of the Study:
- To review evidence on the efficacy of pharmacological agents in managing hypercholesterolemia.
- To assess the impact of cholesterol-lowering treatments on CHD risk.
Main Methods:
- A systematic literature search of PubMed/Medline from 1998-2009.
- Selection of English-language papers using keywords related to hypercholesterolemia management and risk factors.
Main Results:
- Over 3500 reports were identified, with key publications selected.
- Evidence supports the use of various pharmacological agents for cholesterol reduction.
Conclusions:
- Multiple pharmacological options are available for hypercholesterolemia management.
- Evidence supports population-level risk factor modification for reducing CHD.
- A favorable risk profile has significant potential to decrease the global CHD burden.
Introduction:
Coronary heart disease (CHD) is the leading cause of mortality worldwide. With increasingly urbanized lifestyles in developing countries and the aging populations, the major risk factors for CHD such as obesity, diabetes mellitus, and hypercholesterolemia are likely to increase in the future. In the current report, we reviewed the evidence on the effect of cholesterol lowering using pharmacological agents.
Methods:
A PubMed/Medline systematic search was performed over the past 12 years (1998-2009 inclusive) and relevant papers written in the English language were selected. We used key phrases including, "risk factors for hypercholesterolemia," "management of hypercholesterolemia," "guidelines for management of hypercholesterolemia," and "pharmacological management of hypercholesterolemia."
Results:
There were a total of over 3500 reports. We selected key publications on the effect of cholesterol lowering using different pharmacological agents.
Conclusion:
Several options exist with regards to pharmacological management of hypercholesterolemia. There is a substantial body of evidence to support the effect of a population shift towards a favorable risk profile, which has huge potential in reducing the burden of CHD globally.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements